If you enjoy this content, please share it with a colleague
RELATED CONTENT
Viatronix Inc. announced its dedicated CT Colonography (CTC) software V3D-Colon was exclusively used in another important clinical study relating to colorectal cancer screening. The latest CTC study, "Assessment of volumetric growth rates of small colorectal polyps with CT colonography: a longitudinal study of natural history" (Lancet Oncology) tracked polyp growth in 243 patients over an eight year period.
July 23, 2012 — Viatronix Incorp. announced that the stage finally appears set for a reversal of the May 2009 non-coverage decision for screening CT Colongraphy (CTC) by The Centers for Medicare and Medicaid Services (CMS). The latest CTC study, "CT Colonography of a Medicare-Aged Population: Outcomes Observed in an Analysis of More Than 1,400 Patients" (American Journal of Roentgenology, AJR2012; 199:W27-W34), provides good evidence that CT Colonography is an effective screening tool for colorectal cancer in the Medicare-aged population. The lack of Medicare-age specific data on CTC was the primary reason given for CMS' non-coverage decision.
May 29. 2012 — Viatronix Inc., developer of 2-D/3-D medical imaging and diagnostic software, announced that its V3D-Colon platform was exclusively used to perform a key study recently published in the Annals of Internal Medicine. The purpose of the study was to determine the feasibility of a laxative-free bowel prep for patients undergoing a virtual colonoscopy (VC) screening exam. The trial utilized a modified version of the Viatronix V3D-Colon software.
October 5, 2009 - The 2009 Frost & Sullivan European Medical Imaging Emerging Company of the Year Award in the radiology applications market is conferred on Viatronix for its innovative 3D computer imaging technologies in the diagnostic imaging space.
December 8, 2008 - Viatronix Inc., a developer of 3D imaging software, reported it received FDA 510(k) market clearance for its V3D-Cardiac module.
November 24, 2008 - Visage Imaging signed a comprehensive marketing agreement with Viatronix, a developer of 2D/3D medical imaging and diagnostic software, in which Visage Imaging will act as a representative for Viatronix’s V3D-Colon Virtual Colonoscopy product in the U.S.
Viatronix Inc. will release enhancements to its V3D-Colon including a Colon CAD interface that reportedly seamlessly ...
Viatronix Inc. will release enhancements to its V3D-Colon including a Colon CAD interface that reportedly seamlessly ...
September 5, 2007 - Viatronix Inc., a developer of 3D imaging software and Vertec Scientific Ltd., its U.K. based ...
June 13, 2007 – New York based Viatronix Inc. and Medicsight PLC headquartered in London, announced today their recent ...